Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

1-25 of 264 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications.
Shaban N, Kamashev D, Emelianova A, Buzdin A
Cells, 13(1):47, 25 Dec 2023
Cited by: 5 articles | PMID: 38201251 | PMCID: PMC10778338
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Busting the Breast Cancer with AstraZeneca's Gefitinib.
Chemmalar S, Intan Shameha AR, Che Abdullah CA, Ab Razak NA, Yusof LM, Ajat M, Chan KW, Abu Bakar Zakaria MZ
Adv Pharmacol Pharm Sci, 2023:8127695, 04 Dec 2023
Cited by: 1 article | PMID: 38090376 | PMCID: PMC10713255
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer.
Stella GM, Lettieri S, Piloni D, Ferrarotti I, Perrotta F, Corsico AG, Bortolotto C
Pharmaceuticals (Basel), 16(7):1042, 22 Jul 2023
Cited by: 1 article | PMID: 37513953 | PMCID: PMC10385174
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Singareeka Raghavendra A, Yang-Kolodji G, Chu F, Neelapu SS, Marchese A, Hanash S, Zimmermann J, Arteaga CL, Tripathy D
Breast Cancer Res, 25(1):62, 06 Jun 2023
Cited by: 3 articles | PMID: 37280713 | PMCID: PMC10245436
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy.
Wu Q, Sharma D
Cells, 12(8):1156, 14 Apr 2023
Cited by: 12 articles | PMID: 37190065 | PMCID: PMC10136604
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
HER3 Alterations in Cancer and Potential Clinical Implications.
Kilroy MK, Park S, Feroz W, Patel H, Mishra R, Alanazi S, Garrett JT
Cancers (Basel), 14(24):6174, 14 Dec 2022
Cited by: 6 articles | PMID: 36551663 | PMCID: PMC9776947
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation.
Iqbal MJ, Javed Z, Herrera-Bravo J, Sadia H, Anum F, Raza S, Tahir A, Shahwani MN, Sharifi-Rad J, Calina D, Cho WC
Cancer Cell Int, 22(1):354, 15 Nov 2022
Cited by: 11 articles | PMID: 36376956 | PMCID: PMC9664821
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC, Chen BS
Int J Mol Sci, 23(18):10409, 08 Sep 2022
Cited by: 1 article | PMID: 36142321 | PMCID: PMC9499358
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells.
Maniam S, Maniam S
Int J Mol Sci, 22(18):9722, 08 Sep 2021
Cited by: 12 articles | PMID: 34575883 | PMCID: PMC8465612
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.
Saddozai UAK, Wang F, Akbar MU, Zhang L, An Y, Zhu W, Xie L, Li Y, Ji X, Guo X
Front Endocrinol (Lausanne), 12:605797, 21 Jun 2021
Cited by: 3 articles | PMID: 34234737 | PMCID: PMC8256389
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?
Mollaei M, Hassan ZM, Khorshidi F, Langroudi L
Transl Oncol, 14(5):101056, 06 Mar 2021
Cited by: 15 articles | PMID: 33684837 | PMCID: PMC7938256
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance.
Zhang Y
Pharmacol Ther, 218:107677, 06 Sep 2020
Cited by: 23 articles | PMID: 32898548 | PMCID: PMC7855784
Add to export list Review Free full text in Europe PMC
Cytotoxic Effects of the Dual ErbB Tyrosine Kinase Inhibitor, Lapatinib, on Walker 256 Rat Breast Tumour and IEC-6 Rat Normal Small Intestinal Cell Lines.
Wan Mohamad Zain WNIZ, Bowen J, Bateman E, Keefe D
Biomedicines, 8(1):E2, 30 Dec 2019
Cited by: 3 articles | PMID: 31905843 | PMCID: PMC7167933
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
Maher M, Kassab AE, Zaher AF, Mahmoud Z
J Enzyme Inhib Med Chem, 34(1):532-546, 01 Dec 2019
Cited by: 21 articles | PMID: 30688116 | PMCID: PMC6352943
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Combination strategies based on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for cancer patients: Pooled analysis and subgroup analysis of efficacy and safety.
Xu R, Shao H, Zhu J, Ju Q, Shi H
Medicine (Baltimore), 98(13):e14135, 01 Mar 2019
Cited by: 3 articles | PMID: 30921175 | PMCID: PMC6456063
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer.
Yang L, Li Y, Bhattacharya A, Zhang Y
Sci Transl Med, 11(476):eaav1620, 01 Jan 2019
Cited by: 18 articles | PMID: 30674653 | PMCID: PMC6409101
Add to export list Free full text in Europe PMC
The Role of PI3K in Met Driven Cancer: A Recap.
Hervieu A, Kermorgant S
Front Mol Biosci, 5:86, 24 Oct 2018
Cited by: 22 articles | PMID: 30406111 | PMCID: PMC6207648
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Studies on the Dual Activity of EGFR and HER-2 Inhibitors Using Structure-Based Drug Design Techniques.
de Angelo RM, Almeida MO, de Paula H, Honorio KM
Int J Mol Sci, 19(12):E3728, 23 Nov 2018
Cited by: 4 articles | PMID: 30477154 | PMCID: PMC6321113
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors.
Moore KN, Bendell JC, LoRusso PM, Olszanski AJ, Zwick-Wallasch E, Jansen M, Vandell AG, Senaldi G
Invest New Drugs, 37(1):147-158, 28 Jul 2018
Cited by: 4 articles | PMID: 30056611 | PMCID: PMC6886232
Add to export list Free full text in Europe PMC
Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
Morrison J, Thoma C, Goodall RJ, Lyons TJ, Gaitskell K, Wiggans AJ, Bryant A
Cochrane Database Syst Rev, 10:CD007927, 16 Oct 2018
Cited by: 16 articles | PMID: 30321910 | PMCID: PMC6430330
Add to export list Review Free full text in Europe PMC
Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine Resistance.
Montaser RZ, Coley HM
Cancers (Basel), 10(6):E209, 20 Jun 2018
Cited by: 8 articles | PMID: 29925812 | PMCID: PMC6025235
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Drug-Triggered Self-Assembly of Linear Polymer into Nanoparticles for Simultaneous Delivery of Hydrophobic and Hydrophilic Drugs in Breast Cancer Cells.
Palvai S, Anandi L, Sarkar S, Augustus M, Roy S, Lahiri M, Basu S
ACS Omega, 2(12):8730-8740, 07 Dec 2017
Cited by: 5 articles | PMID: 30023590 | PMCID: PMC6044771
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Suppressors for Human Epidermal Growth Factor Receptor 2/4 (HER2/4): A New Family of Anti-Toxoplasmic Agents in ARPE-19 Cells.
Kim YH, Bhatt L, Ahn HJ, Yang Z, Lee WK, Nam HW
Korean J Parasitol, 55(5):491-503, 31 Oct 2017
Cited by: 2 articles | PMID: 29103264 | PMCID: PMC5678465
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma.
Chen T, Zhou L, Li H, Tian Y, Li J, Dong L, Zhao Y, Wei D
Oncol Lett, 14(5):5934-5946, 15 Sep 2017
Cited by: 12 articles | PMID: 29113229 | PMCID: PMC5661422
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
Martin JL, Julovi SM, Lin MZ, de Silva HC, Boyle FM, Baxter RC
Breast Cancer Res, 19(1):90, 04 Aug 2017
Cited by: 14 articles | PMID: 28778177 | PMCID: PMC5545026
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 264 results

1 2 3 Next ...

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

Partnerships & funding